Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xvivo Perfusion

Clinical trials sponsored by Xvivo Perfusion, explained in plain language.

Xvivo Perfusion XVIVO NASDAQ STOCKHOLM

Medical technology for organ preservation and transplantation.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 4

New device could keep donor livers healthier before transplant

Disease control Not yet recruiting

This study tests a device that keeps donor livers cool and oxygenated before transplant, aiming to reduce early liver problems. About 215 first-time liver transplant patients will receive a liver preserved with this method. The goal is to see if it lowers the risk of early graft …

Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC